Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy
Journal of Medicinal Chemistry · 27.03.2025 · 68 (6) · 6558-6575
DOI: 10.1021/acs.jmedchem.4c03127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.03.2025. Verfasst von Maude Giroud und 30 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland. Hauptthemen laut MEDLINE: Armadillo Domain Proteins, Cytoskeletal Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Sterile alpha and TIR Motif Containing 1 (SARM1) is a nicotinamide adenine dinucleotide (NAD+) hydrolase that plays a central role in programmed axonal degeneration. Axonal degeneration has been linked to neurodegenerative and neurological disorders such as multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, and peripheral neuropathies. Therefore, developing potent and selective SARM1 inhibitors could be an effective strategy to treat these disorders. We present herein the structure-guided discovery of two novel SARM1 inhibitors, 7 and 35. Compounds 7 and 35 are potent inhibitors across assays and possess favorable ADMET properties. When tested in vivo, compound 7 showed efficacy after oral dosing in a mouse model of peripheral nerve injury by decreasing plasma neurofilament light (NfL) levels at 50 mg/kg compared with vehicle-treated control mice, holding promise for the treatment of neurodegenerative and neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland.
ORCID-Profile: Maude Giroud, Bernd Kuhn, Paul Westwood, Wolfgang Haap, Uwe Grether, Nina Aregger, Matthias Beat Wittwer
Zitieren
APA
Giroud, M., Kuhn, B., Steiner, S., Westwood, P., Mendel, M., Mani, A., Pinard, E., Haap, W., Grether, U., Caramenti, P., Rombach, D., Zambaldo, C., Ritter, M., Schmid, P., Gasser, C., Aregger, N., Séchet, N., Topp, A., Bilyard, M., …, & Keaney, J. (2025). Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy. Journal of Medicinal Chemistry, 68(6), 6558-6575. https://doi.org/10.1021/acs.jmedchem.4c03127
Vancouver
Giroud M, Kuhn B, Steiner S, Westwood P, Mendel M, Mani A, et al. Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy. Journal of Medicinal Chemistry. 2025;68(6):6558-6575. doi:10.1021/acs.jmedchem.4c03127
BibTeX
@article{Giroud2025,
author = {Giroud, Maude and Kuhn, Bernd and Steiner, Sandra and Westwood, Paul and Mendel, Mateusz and Mani, Anisha and Pinard, Emmanuel and Haap, Wolfgang and Grether, Uwe and Caramenti, Paola and Rombach, Didier and Zambaldo, Claudio and Ritter, Martin and Schmid, Philipp and Gasser, Claire and Aregger, Nina and Séchet, Nora and Topp, Andreas and Bilyard, Matthew and Malnight-Alvarez, Alexia and Plitzko, Inken and Hilbert, Manuel and Kalayil, Sissy and Burger, Dominique and Bonardi, Claudia and Saal, Wiebke and Haider, Achi and Wittwer, Matthias Beat and Brigo, Alessandro and Benz, Jörg and Keaney, James},
title = {Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {6},
pages = {6558--6575},
doi = {10.1021/acs.jmedchem.4c03127}
}
EUVIMED